Clostridium difficile infection in lung cancer patients

Japanese Journal of Infectious Diseases

Volumn 66, Issue 5, 2013, Pages 379-382

  Hwang, Ki Eun ^a,b   Hwang, Yu Ri ^a   Seol, Chang Hwan ^a   Chul Park, ^a   Park, Seong Hoon ^a   Yoon, Kwon Ha ^a   Park, Do Sim ^a   Lee, Mi Kyung ^a   Jeong, Eun Taik ^a   Kim, Hak Ryul ^a  

^a Wonkwang University School of Medicine   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Albumin and performance status score; Clostridium difficile infection; Lung cancer

Indexed keywords

ALBUMIN; BACTERIAL TOXIN; CEPHALOSPORIN; MACROLIDE; METRONIDAZOLE; PLATINUM DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR; QUINOLONE; VANCOMYCIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOSCOPY; ENDOTOXIN DETECTION; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; KARNOFSKY PERFORMANCE STATUS; LENGTH OF STAY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84884369201     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.379     Document Type: Article

References (24)

1. Soares, M., Darmon, M., Salluh, J.I., et al. (2007): Prognosis of lung cancer patients with life-threatening complications. Chest, 131, 840-846.
2. Andreájak, C., Terzi, N., Thielen, S., et al. (2011): Admission of advanced lung cancer patients to intensive care unit: a retrospective study of 76 patients. BMC Cancer, 11, 159.
3. Kelly, C.P., Pothoulakis, C. and LaMont, J.T. (1994): Clostridium difficile colitis. N. Engl. J. Med., 330, 257-262.
4. Bartlett, J.G. (1992): Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med., 346, 334-339.
5. Anand, A. and Glatt, A.E. (1993): Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin. Infect. Dis., 17, 109-113.
6. Morales Chamorro, R., Serrano Blanch, R., Mendez Vidal, M.J., et al. (2005): Pseudomembranouscolitis associated with chemotherapy with 5-fluorouracil. Clin. Transl. Oncol., 7, 258-261.
7. Bilgrami, S., Feingold, J.M., Dorsky, D., et al. (1999): Incidence and outcome of Clostridium difficile infection following autologous peripheral bloodstem cell transplantation. Bone Marrow Transplant., 23, 1039-1042.
8. Gorschluter, M., Glasmacher, A., Hahn, C., et al. (2001): Clostridium difficile infection in patients with neutropenia. Clin. Infect. Dis., 33, 786-791.
9. Mountain, C.F. (1997): Revision in the international system forstaging lung cancer. Chest, 111, 1710-1717.
10. Demetri, G., Elias, A., Gershenson, D., et al. (1996): NCCN Small-cell lung cancer practice guidelines. The national comprehensive cancer network. Oncology, 10, 179-194.
11. Cohen, S.H., Gerding, D.N., Johnson, S., et al. (2010): Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol., 31, 431-455.
12. Pepin, J., Alary, M.E., Valiquette, L., et al. (2005): Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin. Infect. Dis., 40, 1591-1597.
13. Stewart, D.B., Yacoub, E. and Zhu, J. (2012): Chemotherapy patients with C. difficile colitis have outcomes similar to immunocompetent C. difficile patients. J. Gastrointest. Surg., 16, 1566-1572.
14. Kamthan, A.G., Bruckner, H.W., Hirschman, S.Z., et al. (1992): Clostridium difficile diarrhea induced by cancer chemotherapy. Arch. Intern. Med., 152, 1715-1717.
15. Leonard, J., Marshall, J.K. and Moayyedi, P. (2007): Systematic review of the risk of enteric infection in patients taking acid suppression. Am. J. Gastroenterol., 102, 2047-2056.
16. Dial, S., Delaney, J.A., Barkun, A.N., et al. (2005): Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA, 294, 2989-2995.
17. Surawicz, C.M. (2009): Reining in recurrent Clostridium difficile infection-who's at risk? Gastroenterology, 136, 1152-1154.
18. Ramaswamy, R., Grover, H., Corpuz, M., et al. (1996): Prognostic criteria in Clostridium difficile colitis. Am. J. Gastroenterol., 91, 460-463.
19. Al-Tureihi, F.I., Hassoun, A., Wolf-Klein, G., et al. (2005): Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients. J. Am. Med. Dir. Assoc., 6, 105-108.
20. Christodoulou, C., Rizos, M., Galani, E., et al. (2007): Performance status (PS): a simple predictor of short-term outcome of cancer patients with solid tumors admitted to the intensive care unit (ICU). Anticancer Res., 27, 2945-2948.
21. McFarland, L.V., Mulligan, M.E., Kwok, R.Y., et al. (1989): Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med., 320, 204-210.
22. Triadafilopoulos, G. and Hallstone, A.E. (1991): Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology, 101, 685-691.
23. Voth, D.E. and Ballard, J.D. (2005): Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev., 18, 247-263.
24. Loo, V.G., Poirier, L., Miller, M.A., et al. (2005): A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med., 353, 2442-2449.